We recently selected DNA aptamers that bind to camptothecin (CPT) and CPT derivatives from a 70-mer oligodeoxyribonucleotide (ODN) library using the Systematic Evolution of Ligands by EXponential enrichment (SELEX) method. The target-binding activity of the obtained 70-mer CPT-binding DNA aptamer, termed CA-70, which contains a 16-mer guanine (G)-core motif (G 3TG 3TG 3T 2G 3) that forms a three-tiered G-quadruplex, was determined using fluorescence titration. In this study, truncated fragments of CA-70 that all have the G-core motif, CA-40, -20, -19, -18A, -18B, -17, and -16, were carefully analyzed. We found that CA-40 retained the target-binding activity, whereas CA-20, -19, and -18B exhibited little or no binding activities. Further, not only CA-18A but also the shorter length fragments CA-17 and -16 clearly retained the binding activity, indicating that tail strands of the G-quadruplex structure can significantly affect the target binding of G-quadruplex DNA aptamers. Further analyses using circular dichroism (CD) spectroscopy and fluorescence polarization (FP) assay were conducted to investigate the structure and affinity of G-quadruplex DNA aptamers.
References
[1]
Ellington, A.D.; Szostak, J.W. In vitro selection of RNA molecules that bind specific ligands. Nature 1990, 346, 818–822, doi:10.1038/346818a0.
[2]
Tuerk, C.; Gold, L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990, 249, 505–510.
[3]
Ellington, A.D.; Szostak, J.W. Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures. Nature 1992, 355, 850–852, doi:10.1038/355850a0.
[4]
Sissi, C.; Gatto, B.; Palumbo, M. The evolving world of protein-G-quadruplex recognition: a medicinal chemist’s perspective. Biochimie 2011, 93, 1219–1230, doi:10.1016/j.biochi.2011.04.018.
[5]
Hamon, F.; Faverie, A.; Renaud, F.A.; Hamon, F.; Di Primo, C.; Largy, E.; Dausse, E.; Delaurière, L.; Landras-Guetta, C.; Toulmé, J.J.; et al. Nucleic acids targeted to drugs: SELEX against a quadruplex ligand. Biochimie 2011, 93, 1357–1367, doi:10.1016/j.biochi.2011.05.022.
[6]
Tucker, W.O.; Shum, K.T.; Tanner, J.A. G-quadruplex DNA aptamers and their ligands: Structure, function and application. Curr. Pharm. Des. 2012, 18, 2014–2026, doi:10.2174/138161212799958477.
[7]
Nadai, M.; Sattin, G.; Palù, G.; Palumbo, M.; Richter, S.N. Clerocidin-mediated DNA footprinting discriminates among different G-quadruplex conformations and detects tetraplex folding in a duplex environment. Biochim. Biophys. Acta 2013, 1830, 4660–4668, doi:10.1016/j.bbagen.2013.05.039.
[8]
Gatto, B.; Palumbo, M.; Sissi, C. Nucleic acid aptamers based on the G-quadruplex structure: therapeutic and diagnostic potential. Curr. Med. Chem. 2009, 16, 1248–1265, doi:10.2174/092986709787846640.
Nagatoishi, S.; Isono, N.; Tsumoto, K.; Sugimoto, N. Loop residues of thrombin-binding DNA aptamer impact G-quadruplex stability and thrombin binding. Biochimie 2011, 93, 1231–1238, doi:10.1016/j.biochi.2011.03.013.
[11]
Nagatoishi, S.; Sugimoto, N. Interaction of water with the G-quadruplex loop contributes to the binding energy of G-quadruplex to protein. Mol. Biosyst. 2012, 8, 2766–2770, doi:10.1039/c2mb25234a.
[12]
Pramanik, S.; Nagatoishi, S.; Sugimoto, N. DNA tetraplex structure formation from human telomeric repeat motif (TTAGGG):(CCCTAA) in nanocavity water pools of reverse micelles. Chem. Commun. 2012, 48, 4815–4817, doi:10.1039/c2cc30622k.
[13]
Imaizumi, Y.; Kasahara, Y.; Fujita, H.; Kitadume, S.; Ozaki, H.; Endoh, T.; Kuwahara, M.; Sugimoto, N. Efficacy of base-modification on target binding of small molecule DNA aptamers. J. Am. Chem. Soc. 2013, 135, 9412–9419, doi:10.1021/ja4012222.
[14]
McLuckie, K.I.; Waller, Z.A.; Sanders, D.A.; Alves, D.; Rodriguez, R.; Dash, J.; McKenzie, G.J.; Venkitaraman, A.R.; Balasubramanian, S. G-quadruplex-binding benzo[a]phenoxazines down-regulate c-KIT expression in human gastric carcinoma cells. J. Am. Chem. Soc. 2011, 133, 2658–2663, doi:10.1021/ja109474c.
[15]
Hurley, L.H.; von Hoff, D.D.; Siddiqui-Jain, A.; Yang, D. Drug targeting of the c-MYC promoter to repress gene expression via a G-quadruplex silencer element. Semin. Oncol. 2006, 33, 498–512, doi:10.1053/j.seminoncol.2006.04.012.
[16]
Shoji, A.; Hasegawa, T.; Kuwahara, M.; Ozaki, H.; Sawai, H. Chemico-enzymatic synthesis of a new fluorescent-labeled DNA by PCR with a thymidine nucleotide analogue bearing an acridone derivative. Bioorg. Med. Chem. Lett. 2007, 17, 776–779, doi:10.1016/j.bmcl.2006.10.072.
[17]
Beno, I.; Rosenthal, K.; Levitine, M.; Shaulov, L.; Haran, T.E. Sequence-dependent cooperative binding of p53 to DNA targets and its relationship to the structural properties of the DNA targets. Nucleic Acids Res. 2011, 39, 1919–1932, doi:10.1093/nar/gkq1044.
[18]
Nagesh, N.; Sharma, V.K.; Ganesh, K.A.; Lewis, E.A. Effect of Ionic Strength on Porphyrin Drugs Interaction with Quadruplex DNA Formed by the Promoter Region of C-myc and Bcl2 Oncogenes. J. Nucleic Acids 2010, 2010, 146418.
[19]
Jecklin, M.C.; Schauer, S.; Dumelin, C.E.; Zenobi, R. Label-free determination of protein-ligand binding constants using mass spectrometry and validation using surface plasmon resonance and isothermal titration calorimetry. J. Mol. Recognit. 2009, 22, 319–329, doi:10.1002/jmr.951.
[20]
Ruta, J.; Perrier, S.; Ravelet, C.; Fize, J.; Peyrin, E. Noncompetitive fluorescence polarization aptamer-based assay for small molecule detection. Anal. Chem. 2009, 81, 7468–7473, doi:10.1021/ac9014512.
[21]
Mohanty, J.; Barooah, N.; Dhamodharan, V.; Harikrishna, S.; Pradeepkumar, P.I.; Bhasikuttan, A.C. Thioflavin T as an efficient inducer and selective fluorescent sensor for the human telomeric G-quadruplex DNA. J. Am. Chem. Soc. 2013, 135, 367–376, doi:10.1021/ja309588h.
[22]
Chen, S.B.; Shi, Q.X.; Peng, D.; Huang, S.Y.; Ou, T.M.; Li, D.; Tan, J.H.; Gu, L.Q.; Huang, Z.S. The role of positive charges on G-quadruplex binding small molecules: Learning from bisaryldiketene derivatives. Biochim Biophys Acta 2013, 1830, 5006–5013, doi:10.1016/j.bbagen.2013.07.012.
[23]
Shi, S.; Huang, H.L.; Gao, X.; Yao, J.L.; Lv, C.Y.; Zhao, J.; Sun, W.L.; Yao, T.M.; Ji, L.N. A comparative study of the interaction of two structurally analogous ruthenium complexes with human telomeric G-quadruplex DNA. J. Inorg. Biochem. 2013, 121, 19–27, doi:10.1016/j.jinorgbio.2012.12.011.
[24]
SantaLucia, J., Jr. A unified view of polymer, dumbbell, and oligonucleotide DNA nearest-neighbor thermodynamics. Proc. Natl. Acad. Sci. USA 1998, 95, 1460–1465, doi:10.1073/pnas.95.4.1460.
[25]
Zuker, M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 2003, 31, 3406–3415, doi:10.1093/nar/gkg595.
[26]
Sen, D.; Gilbert, W. Formation of parallel four-stranded complexes by guanine-rich motifs in DNA and its implications for meiosis. Nature 1988, 334, 364–366, doi:10.1038/334364a0.
Kasahara, Y.; Irisawa, Y.; Fujita, H.; Yahara, A.; Ozaki, H.; Obika, S.; Kuwahara, M. Capillary electrophoresis-systematic evolution of ligands by exponential enrichment selection of base- and sugar-modified DNA aptamers: target binding dominated by 2'-O,4'-C-methylene-bridged/locked nucleic acid primer. Anal. Chem. 2013, 85, 4961–4967, doi:10.1021/ac400058z.
[29]
Seenisamy, J.; Rezler, E.M.; Powell, T.J.; Tye, D.; Gokhale, V.; Joshi, C.S. Siddiqui-Jain, A.; Hurley, L.H. The dynamic character of the G-quadruplex element in the c-MYC promoter and modification by TMPyP4. J. Am. Chem. Soc. 2004, 126, 8702–8709, doi:10.1021/ja040022b.
[30]
Kang, H.J.; Park, H.J. Novel molecular mechanism for actinomycin D activity as an oncogenic promoter G-quadruplex binder. Biochemistry 2009, 48, 7392–7398, doi:10.1021/bi9006836.
